1,3-Dimethylamylamine is also known as methylhexan(e)amine and many trade names. In 1944 and 1945, Eli Lilly was awarded US patents for its synthesis; and beginning in 1971, it was marketed by Lilly as a nasal decongestant. It is also sold as a dietary supplement and stimulant. In 2010, the World Anti-Doping Agency added it to the list of substances prohibited for use by athletes.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.